'2002 vrbpac' diaporamas de présentation

Update from the Office of Vaccines Research and Review, CBER/FDA

Update from the Office of Vaccines Research and Review, CBER/FDA. NVAC Meeting Washington, D.C. February 4-5, 2003. New Approvals since October 2002 NVAC Meeting. FDA licensed a new combination vaccine containing DTaP, hepatitis B, and IPV in 12/02 Marketed as Pediarix ™ by GSK

143 views • 5 slides